ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
BN
Basingstoke and North Hampshire Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Basingstoke and North Hampshire Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its work explores cancer outcomes and risk factors across several tumour types. It examines whether surgery benefits older people with gallbladder cancer and how a methylation marker may predict glioblastoma outcomes.
| Organization | ESMO 2026 Attendance |
|---|---|
BN Basingstoke and North Hampshire Hospital Basingstoke, United Kingdom | |
General hospital in Basingstoke, United Kingdom, operated by Hampshire Hospitals NHS Foundation Trust. | Poster Fri Oct 23 13:00–15:00 CXorf40A / EOLA1 methylation as a male-specific prognostic biomarker in glioblastoma multiforme Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 The effect of surgical resection on survival of older patients with adrenocortical carcinoma: A population-based competing-risk survival analysis Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Basingstoke and North Hampshire Hospital
Tell us what you sell and we’ll find the people at Basingstoke and North Hampshire Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction